ATXS vs VFC · rev $706.0K vs P/E 26, rev $9.61B
Astria Therapeutics Inc (ATXS) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported VFC revenue for 2026-03-28 was $9.61B. Net income was $254.9M. Revenue was up 1.1% from 2025-03-29 to 2026-03-28. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
ATXS currently screens at market cap $382.1M. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the ATXS and VFC stock pages for the full models.
Not investment advice.